2-38985880-G-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4BP6BS1BS2
The NM_005633.4(SOS1):āc.3946C>Gā(p.His1316Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000719 in 1,613,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005633.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251318Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135816
GnomAD4 exome AF: 0.0000670 AC: 98AN: 1461642Hom.: 0 Cov.: 32 AF XY: 0.0000578 AC XY: 42AN XY: 727118
GnomAD4 genome AF: 0.000118 AC: 18AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74454
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
The p.H1316D variant (also known as c.3946C>G), located in coding exon 23 of the SOS1 gene, results from a C to G substitution at nucleotide position 3946. The histidine at codon 1316 is replaced by aspartic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Benign:1
Variant summary: SOS1 c.3946C>G (p.His1316Asp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 251318 control chromosomes (gnomAD). The observed variant frequency is approximately 3.7 fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS1 causing Noonan Syndrome phenotype (3e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.3946C>G in individuals affected with Noonan Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -
not provided Benign:1
Has not been previously published as pathogenic or benign to our knowledge -
RASopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at